Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Renal Cell 46Sarcoma 21Neoplasms 18Neoplasm Metastasis 15Ovarian Neoplasms 12Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Recurrence 5Melanoma 5Fallopian Tube Neoplasms 5Thyroid Neoplasms 4Prostatic Neoplasms 4Liposarcoma 4Hemangiosarcoma 4Urinary Bladder Neoplasms 3Solid Tumors 3Lung Neoplasms 3Leiomyosarcoma 3Kidney Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Clear-cell metastatic renal cell carcinoma 3Carcinoma, Ovarian Epithelial 3Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Refractory Solid Tumors 2Neuroendocrine Tumors 2Gliosarcoma 2Financial Stress 2Chondrosarcoma, Extraskeletal Myxoid 2

Interventions

Paclitaxel 2Carboplatin 2pazopanib 1Isotretinoin 1Fluorouracil 1Filgrastim 1Educational Status 1Conization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Diseases × pazopanib × Clear all
NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

GlaxoSmithKline

Phase 2 Completed
12 enrolled 6 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡